These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 16626892

  • 1. Radiation dose to the internal pudendal arteries from permanent-seed prostate brachytherapy as determined by time-of-flight MR angiography.
    Gillan C, Kirilova A, Landon A, Yeung I, Pond G, Crook J.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):688-93. PubMed ID: 16626892
    [Abstract] [Full Text] [Related]

  • 2. Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy.
    Taussky D, Haider M, McLean M, Yeung I, Williams T, Pearson S, Lockwood G, Crook J.
    Brachytherapy; 2004 Jul 01; 3(3):125-9. PubMed ID: 15533803
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry.
    Neill M, Studer G, Le L, McLean M, Yeung I, Pond G, Crook JM.
    Brachytherapy; 2007 Jul 01; 6(3):173-9. PubMed ID: 17681239
    [Abstract] [Full Text] [Related]

  • 5. Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients.
    Tanaka N, Asakawa I, Kondo H, Tanaka M, Fujimoto K, Hasegawa M, Konishi N, Hirao Y.
    Int J Urol; 2009 Jan 01; 16(1):70-4. PubMed ID: 19120529
    [Abstract] [Full Text] [Related]

  • 6. The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer.
    Ash D, Al-Qaisieh B, Bottomley D, Carey B, Joseph J.
    Radiother Oncol; 2006 May 01; 79(2):185-9. PubMed ID: 16701911
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
    Beaulieu L, Archambault L, Aubin S, Oral E, Taschereau R, Pouliot J.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1298-308. PubMed ID: 15001275
    [Abstract] [Full Text] [Related]

  • 12. MRI-based preplanning in low-dose-rate prostate brachytherapy.
    Tanaka O, Hayashi S, Matsuo M, Nakano M, Kubota Y, Maeda S, Ohtakara K, Deguchi T, Hoshi H.
    Radiother Oncol; 2008 Jul 15; 88(1):115-20. PubMed ID: 17933407
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative study of dosimetry between high-dose-rate and permanent prostate implant brachytherapies in patients with prostate adenocarcinoma.
    Wang Y, Sankreacha R, Al-Hebshi A, Loblaw A, Morton G.
    Brachytherapy; 2006 Jul 15; 5(4):251-5. PubMed ID: 17118319
    [Abstract] [Full Text] [Related]

  • 15. Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer.
    Saibishkumar EP, Borg J, Yeung I, Cummins-Holder C, Landon A, Crook JM.
    Brachytherapy; 2008 Jul 15; 7(2):200-5. PubMed ID: 18362087
    [Abstract] [Full Text] [Related]

  • 16. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
    Nobes JP, Khaksar SJ, Hawkins MA, Cunningham MJ, Langley SE, Laing RW.
    Radiother Oncol; 2008 Jul 15; 88(1):121-6. PubMed ID: 18499289
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy.
    Crook J, Gillan C, Yeung I, Austen L, McLean M, Lockwood G.
    Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):426-33. PubMed ID: 17869662
    [Abstract] [Full Text] [Related]

  • 19. Four-year experience of interstitial permanent brachytherapy for Japanese men with localized prostate cancer.
    Ishiyama H, Satoh T, Kitano M, Tsumura H, Kotani S, Okusa H, Uemae M, Baba S, Hayakawa K.
    Jpn J Clin Oncol; 2008 Jul 01; 38(7):469-73. PubMed ID: 18577509
    [Abstract] [Full Text] [Related]

  • 20. Intraoperative adaptive brachytherapy of iodine-125 prostate implants guided by C-arm cone-beam computed tomography-based dosimetry.
    Westendorp H, Hoekstra CJ, van't Riet A, Minken AW, Immerzeel JJ.
    Brachytherapy; 2007 Jul 01; 6(4):231-7. PubMed ID: 17991620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.